Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Clinical trial NCT01696500 · COMPLETED

Trial details

NCT number: NCT01696500
Sponsor: Nihon Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stevens-Johnson Syndrome Toxic Epidermal Necrolysis

Start date: 2012-10-01
Primary completion: 2014-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.